Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition - CNBC TV18
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Johnson & Johnson has acquired AtraVerse Medical, a medical devices business in California. AtraVerse Medical develops the HOTWIRE transseptal access system used in cardiac catheterization procedures, supporting transseptal access for electrophysiology and structural heart workflows. The AtraVerse Medical acquisition expands Johnson & Johnson acquisitions in interventional cardiology and strengthens its portfolio of transseptal access technology for clinicians in CA. The healthcare M&A is categorized as other acquisition and strategic acquisition, with deal size undisclosed and status announced, as Johnson & Johnson pursues a medical devices acquisition to accelerate adoption of its transseptal access offerings.
Source
Read full article on prnewswire.comvia GN - entered into definitive agreement · April 24, 2026
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Marksans Pharma→QliniQ
Jun 1, 2026
Frazier Healthcare Partners→Altruix
May 31, 2026
Signos
May 31, 2026
Sterling Bay→Pacific Center
May 29, 2026